Literature DB >> 22906888

Few differences in cytokines between patients newly diagnosed with type 1 diabetes and their healthy siblings.

Jannet Svensson1, Stefanie Eising, David Michael Hougaard, Henrik Bindesbøl Mortensen, Kristin Skogstrand, Lars Bjarke Simonsen, Bendix Carstensen, Anita Nilsson, Åke Lernmark, Flemming Pociot, Jesper Johannesen.   

Abstract

The cause of the worldwide increase in type 1 diabetes (T1D) is largely unknown. T cells are thought to play a role in disease progression. In contemporary research over the last decade, age- and gender-specific serum levels as well as changes of Th1 and Th2-related cytokines are not well described. From a population-based register of children diagnosed from 1997 to 2005 this study explores eight different cytokines at time of diagnosis. Only TGF-β and IL-18 showed higher levels in patients compared to siblings in an adjusted model (p<0.01); whereas the other seven cytokines were not significantly different. IL-1β, IL-18, IL-12, IL-10 and IL-4 were significantly higher among the youngest children and males had significantly lower levels of IL-10 and IL-12 but higher levels of TNF-α. During the nine-year study all of the cytokines increased except TGF-β, which showed a slight decrease over time. The cytokine levels tended to be highest during summer and were most pronounced for IL-1β and TNF-α. In conclusion, serum levels of known β-cell cytotoxic cytokines were indifferent in patients and siblings, while gender, age and season appear to exert some influence on the serum level and need to be explored further. The influence of time on systemic levels cannot be ignored and may reflect decay or environmental impact on the immune system.
Copyright © 2012 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22906888     DOI: 10.1016/j.humimm.2012.07.337

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  6 in total

Review 1.  Novel biomarkers in type 1 diabetes.

Authors:  Yulan Jin; Jin-Xiong She
Journal:  Rev Diabet Stud       Date:  2012-12-28

Review 2.  Mechanisms of autoimmunity in the non-obese diabetic mouse: effector/regulatory cell equilibrium during peak inflammation.

Authors:  Nadir Askenasy
Journal:  Immunology       Date:  2016-02-08       Impact factor: 7.397

3.  Factors Associated with Higher Pro-Inflammatory Tumor Necrosis Factor-α Levels in Young Women with Type 1 Diabetes.

Authors:  K K Danielson; R S Monson; T J LeCaire
Journal:  Exp Clin Endocrinol Diabetes       Date:  2016-03-23       Impact factor: 2.949

4.  Molecular signatures differentiate immune states in type 1 diabetic families.

Authors:  Yi-Guang Chen; Susanne M Cabrera; Shuang Jia; Mary L Kaldunski; Joanna Kramer; Sami Cheong; Rhonda Geoffrey; Mark F Roethle; Jeffrey E Woodliff; Carla J Greenbaum; Xujing Wang; Martin J Hessner
Journal:  Diabetes       Date:  2014-04-23       Impact factor: 9.461

5.  Increased Blood Levels of Growth Factors, Proinflammatory Cytokines, and Th17 Cytokines in Patients with Newly Diagnosed Type 1 Diabetes.

Authors:  Kristi Alnek; Kalle Kisand; Kaire Heilman; Aleksandr Peet; Karin Varik; Raivo Uibo
Journal:  PLoS One       Date:  2015-12-04       Impact factor: 3.240

6.  Confirmation and Identification of Biomarkers Implicating Environmental Triggers in the Pathogenesis of Type 1 Diabetes.

Authors:  Robert Z Harms; Katie R Ostlund; Monina S Cabrera; Earline Edwards; Marisa Fisher; Nora Sarvetnick
Journal:  Front Immunol       Date:  2020-09-15       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.